Literature DB >> 19258273

Pharmacokinetics of intracameral voriconazole injection.

Ying-Cheng Shen1, Mei-Yen Wang, Chun-Yuan Wang, Tsun-Chung Tsai, Hin-Yeung Tsai, Hsin-Nung Lee, Li-Chen Wei.   

Abstract

Elimination of voriconazole after intracameral injection exhibited an exponential decay with a half-life of 22 min. Voriconazole levels in the vitreous humor were below the detectable limit. The aqueous concentrations achieved with a 25-microg dose during the first 2 h were greater than the previously reported MICs of organisms most involved in fungal endophthalmitis. A rapid decline in intracameral concentration suggests that frequent supplementation of intracameral voriconazole may be required in clinical settings.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19258273      PMCID: PMC2681505          DOI: 10.1128/AAC.01125-08

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  12 in total

1.  Dissecting ocular tissue for intraocular drug studies.

Authors:  R Abel; G L Boyle
Journal:  Invest Ophthalmol       Date:  1976-03

2.  Half-life of intracameral gentamicin after phacoemulsification.

Authors:  O J Lehmann; J P Thompson; L O White; M F Keys; M J Campbell
Journal:  J Cataract Refract Surg       Date:  1997 Jul-Aug       Impact factor: 3.351

3.  Voriconazole concentration in human aqueous humor and plasma during topical or combined topical and systemic administration for fungal keratitis.

Authors:  Michael A Thiel; Annelies S Zinkernagel; Jürgen Burhenne; Claude Kaufmann; Walter E Haefeli
Journal:  Antimicrob Agents Chemother       Date:  2006-10-23       Impact factor: 5.191

4.  Intravitreal voriconazole: an electroretinographic and histopathologic study.

Authors:  Hua Gao; Mark E Pennesi; Kekul Shah; Xiaoxi Qiao; Seenu M Hariprasad; William F Mieler; Samuel M Wu; Eric R Holz
Journal:  Arch Ophthalmol       Date:  2004-11

5.  Voriconazole treatment for less-common, emerging, or refractory fungal infections.

Authors:  John R Perfect; Kieren A Marr; Thomas J Walsh; Richard N Greenberg; Bertrand DuPont; Juliàn de la Torre-Cisneros; Gudrun Just-Nübling; Haran T Schlamm; Irja Lutsar; Ana Espinel-Ingroff; Elizabeth Johnson
Journal:  Clin Infect Dis       Date:  2003-04-22       Impact factor: 9.079

6.  A compartmental model for the ocular pharmacokinetics of cyclosporine in rabbits.

Authors:  C Oh; B A Saville; Y L Cheng; D S Rootman
Journal:  Pharm Res       Date:  1995-03       Impact factor: 4.200

7.  Pharmacokinetics of amikacin and chloramphenicol in the aqueous humor of rabbits.

Authors:  M Mayers; D Rush; A Madu; M Motyl; M H Miller
Journal:  Antimicrob Agents Chemother       Date:  1991-09       Impact factor: 5.191

8.  Clearance of intravitreal voriconazole.

Authors:  Ying-Cheng Shen; Mei-Yen Wang; Chun-Yuan Wang; Tsun-Chung Tsai; Hin-Yeung Tsai; Yi-Fen Lee; Li-Chen Wei
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-05       Impact factor: 4.799

9.  Aqueous and vitreous concentrations following topical administration of 1% voriconazole in humans.

Authors:  G Atma Vemulakonda; Seenu M Hariprasad; William F Mieler; Randall A Prince; Gaurav K Shah; Russell N Van Gelder
Journal:  Arch Ophthalmol       Date:  2008-01

10.  The pharmacokinetics and safety of intravenous voriconazole - a novel wide-spectrum antifungal agent.

Authors:  Lynn Purkins; Nolan Wood; Katie Greenhalgh; Malcolm D Eve; Stuart D Oliver; Don Nichols
Journal:  Br J Clin Pharmacol       Date:  2003-12       Impact factor: 4.335

View more
  7 in total

1.  Supradescemetic voriconazole injection for Candida parapsilosis keratitis.

Authors:  Nikolaos Mamas; Konstantinos Andreanos; Klio Chatzistefanou; Petros Petrou; Dimitrios Brouzas; George Kymionis; Chrysanthi Koutsandrea; Konstantinos Droutsas
Journal:  Int Ophthalmol       Date:  2017-04-18       Impact factor: 2.031

2.  Cytotoxicity of voriconazole on cultured human corneal endothelial cells.

Authors:  Sang Beom Han; Young Joo Shin; Joon Young Hyon; Won Ryang Wee
Journal:  Antimicrob Agents Chemother       Date:  2011-07-18       Impact factor: 5.191

3.  Pharmacokinetics and safety of intravitreal caspofungin.

Authors:  Ying-Cheng Shen; Chiao-Ying Liang; Chun-Yuan Wang; Keng-Hung Lin; Min-Yen Hsu; Hon-Leung Yuen; Li-Chen Wei
Journal:  Antimicrob Agents Chemother       Date:  2014-09-22       Impact factor: 5.191

4.  Comparison of modified corneal cross-linking with intrastromal voriconazole for the treatment of fungal corneal ulcer.

Authors:  Yingxin Chen; Xingya Miao; Minghong Gao; Lixin Song
Journal:  Exp Ther Med       Date:  2021-05-21       Impact factor: 2.447

5.  Treatment with intrastromal and intracameral voriconazole in 2 eyes with Lasiodiplodia theobromae keratitis: case reports.

Authors:  Kaevalin Lekhanont; Manachai Nonpassopon; Nutthida Nimvorapun; Pitak Santanirand
Journal:  Medicine (Baltimore)       Date:  2015-02       Impact factor: 1.889

6.  First case of Kluyveromyces marxianus (Candida kefyr) late onset keratitis after lamellar endothelial corneal graft.

Authors:  Alexander M Aldejohann; Johanna Theuersbacher; Lukas Haug; Olga S Lamm; Grit Walther; Oliver Kurzai; Jost Hillenkamp; Daniel Kampik
Journal:  Med Mycol Case Rep       Date:  2021-02-12

7.  Ineffectiveness of intrastromal voriconazole for filamentous fungal keratitis.

Authors:  Masanori Niki; Hiroshi Eguchi; Yuki Hayashi; Tatsuro Miyamoto; Fumika Hotta; Yoshinori Mitamura
Journal:  Clin Ophthalmol       Date:  2014-06-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.